Immediate Results and Long-Term Clinical Outcome of Patients With Unprotected Distal Left Main Restenosis The CORPAL Registry (Cordoba and Las Palmas)

被引:14
作者
Ojeda, Soledad [1 ]
Pan, Manuel [1 ]
Martin, Pedro [2 ]
Mazuelos, Francisco [1 ]
Suarez de Lezo, Javier [1 ]
Romero, Miguel [1 ]
Segura, Jose [1 ]
Pavlovic, Djordje [1 ]
Medina, Alfonso [2 ]
Suarez de Lezo, Jose [1 ]
机构
[1] Univ Cordoba, Reina Sofia Hosp, Dept Cardiol, IMIBIC, Cordoba, Spain
[2] Univ Las Palmas, Dr Negrin Hosp, Dept Cardiol, Las Palmas Gran Canaria, Spain
关键词
bifurcation lesion; drug-eluting stent(s); left main; restenosis; CORONARY-ARTERY-DISEASE; DRUG-ELUTING STENT; BYPASS-SURGERY; BIFURCATION LESIONS; INTERVENTION; STENOSIS; IMPLANTATION; ANGIOPLASTY; PREDICTORS; CARDIOLOGY;
D O I
10.1016/j.jcin.2013.06.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The goal of this study was to assess the immediate and long-term outcomes in patients undergoing percutaneous coronary intervention (PCI) for in-stent restenosis (ISR) in an unprotected distal left main coronary artery (UDLM). Background PCI for UDLM-ISR can be complex. Limited information is available on procedural and clinical outcomes. Methods Between May 2002 and February 2011, UDLM-ISR after drug-eluting stent implantation was observed in 79 of 1,102 patients (7%). Seventy-five were treated by repeat PCI using a simple approach (balloon/in-stent implantation) or a complex strategy (additional stent/double-stenting technique). A diagnosis of mild or severe restenosis was considered depending on the number of bifurcation segments affected (1 vs. >1). Major adverse cardiac events (MACE) were defined as cardiac death, target lesion revascularization, and myocardial infarction. Results ISR treatment was performed using a simple approach in 44 (58%) patients, and using a complex strategy in 31 (42%). After 46 +/- 26 months, the MACE rate was 22%. Patients treated with a simple approach had a lower incidence of MACE at follow-up compared with patients treated with a complex strategy, regardless of the restenosis extent (mild restenosis: 93% vs. 67%, p < 0.05; severe: 70% vs. 23%, p < 0.05). On Cox regression analysis, diabetes was the only predictor of MACE (hazard ratio [HR]: 4.94; 95% confidence interval [CI]: 1.03 to 23.70; p < 0.05), whereas a simple strategy for ISR treatment was associated with lower risk (HR: 0.25; 95% CI: 0.08 to 0.79; p = 0.02). Conclusions PCI for UDLM-ISR is safe and feasible, with a high rate of procedural success and an acceptable long-term MACE rate. A simple strategy, when applicable, appears to be a good treatment option, associated with a lower event rate at follow-up. (C) 2014 by the American College of Cardiology Foundation
引用
收藏
页码:212 / 221
页数:10
相关论文
共 32 条
[1]   Implantation of a Drug-Eluting Stent With a Different Drug (Switch Strategy) in Patients With Drug-Eluting Stent Restenosis Results From a Prospective Multicenter Study (RIBS III [Restenosis Intra-Stent: Balloon Angioplasty Versus Drug-Eluting Stent]) [J].
Alfonso, Fernando ;
Perez-Vizcayno, Maria J. ;
Dutary, Jaime ;
Zueco, Javier ;
Cequier, Angel ;
Garcia-Touchard, Arturo ;
Marti, Vicens ;
Lozano, Inigo ;
Angel, Juan ;
Hernandez, Jose M. ;
Lopez-Minguez, Jose R. ;
Melgares, Rafael ;
Moreno, Raul ;
Seidelberger, Bernhard ;
Fernandez, Cristina ;
Hernandez, Rosana .
JACC-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (07) :728-737
[2]   Randomized Comparison of Percutaneous Coronary Intervention With Sirolimus-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main Stem Stenosis [J].
Boudriot, Enno ;
Thiele, Holger ;
Walther, Thomas ;
Liebetrau, Christoph ;
Boeckstegers, Peter ;
Pohl, Tilmann ;
Reichart, Bruno ;
Mudra, Harald ;
Beier, Florian ;
Gansera, Brigitte ;
Neumann, Franz-Josef ;
Gick, Michael ;
Zietak, Thomas ;
Desch, Steffen ;
Schuler, Gerhard ;
Mohr, Friedrich-Wilhelm .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (05) :538-545
[3]   Early and Long-Term Results of Unprotected Left Main Coronary Artery Stenting The LE MANS (Left Main Coronary Artery Stenting) Registry [J].
Buszman, Pawel E. ;
Buszman, Piotr P. ;
Kiesz, R. Stefan ;
Bochenek, Andrzej ;
Trela, Blazej ;
Konkolewska, Magda ;
Wallace-Bradley, David ;
Wilczynski, Miroslaw ;
Banasiewicz-Szkrobka, Iwona ;
Peszek-Przybyla, Ewa ;
Krol, Marek ;
Kondys, Marek ;
Milewski, Krzysztof ;
Wiernek, Szymon ;
Debinski, Marcin ;
Zurakowski, Aleksander ;
Martin, Jack L. ;
Tendera, Michal .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (16) :1500-1511
[4]   Long-term outcomes of percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main coronary bifurcation disease in the drug-eluting stent era [J].
Chang, Kiyuk ;
Koh, Yoon-Seok ;
Jeong, Seung Hee ;
Lee, Jong-Min ;
Her, Sung-Ho ;
Park, Hun-Jun ;
Kim, Pum-Joon ;
Kim, Young-Hak ;
Chung, Wook-Sung ;
Yim, Hyeon-Woo ;
Park, Seung-Jung ;
Seung, Ki Bae .
HEART, 2012, 98 (10) :799-805
[5]   Distal Left Main Coronary Bifurcation Lesions Predict Worse Outcome in Patients Undergoing Percutaneous Implantation of Drug-Eluting Stents: Results from the Drug-Eluting Stent for the Treatment of Left Main Disease (DISTAL) Study [J].
Chen, Shao-Liang ;
Ye, Fei ;
Zhang, Jun-jie ;
Liu, Zhi-zhong ;
Lin, Song ;
Zhu, Zhong-Sheng ;
Sun, Xue-wen ;
Li, Feng ;
Zhang, Ai-ping ;
Chen, Jin-guo ;
Ji, Qing-jiong ;
Qian, Jun ;
Chen, Feng ;
Kwan, Tak W. .
CARDIOLOGY, 2009, 113 (04) :264-273
[6]   Early and mid-term results of drug-eluting dtent implantation in unprotected left main [J].
Chieffo, A ;
Stankovic, G ;
Bonizzoni, E ;
Tsagalou, E ;
Iakovou, I ;
Montorfano, M ;
Airoldi, F ;
Michev, I ;
Sangiorgi, MG ;
Carlino, M ;
Vitrella, G ;
Colombo, A .
CIRCULATION, 2005, 111 (06) :791-795
[7]   Drug-Eluting Stent for Left Main Coronary Artery Disease The DELTA Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Left Main Treatment [J].
Chieffo, Alaide ;
Meliga, Emanuele ;
Latib, Azeem ;
Park, Seung-Jung ;
Onuma, Yoshinobu ;
Capranzano, Piera ;
Valgimigli, Marco ;
Jegere, Sanda ;
Makkar, Raj R. ;
Palacios, Igor F. ;
Kim, Young-Hak ;
Buszman, Pawel E. ;
Chakravarty, Tarun ;
Sheiban, Imad ;
Mehran, Roxana ;
Naber, Christoph ;
Margey, Ronan ;
Agnihotri, Arvind ;
Marra, Sebastiano ;
Capodanno, Davide ;
Leon, Martin B. ;
Moses, Jeffrey W. ;
Fajadet, Jean ;
Lefevre, Thierry ;
Morice, Marie-Claude ;
Erglis, Andrejs ;
Tamburino, Corrado ;
Alfieri, Ottavio ;
Serruys, Patrick W. ;
Colombo, Antonio .
JACC-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (07) :718-727
[8]   Angiographic and clinical outcome of percutaneous coronary intervention for in-stent restenosis of bifurcated lesions [J].
Coroleu, Santiago Federico ;
De Vita, Maria ;
Burzotta, Francesco ;
Trani, Carlo ;
Porto, Italo ;
Niccoli, Giampaolo ;
Leone, Antonio Maria ;
Tommasino, Antonella ;
Talarico, Giovanni Paolo ;
Schiavoni, Giovanni ;
Crea, Filippo .
EUROINTERVENTION, 2012, 8 (06) :701-707
[9]   Clinical end points in coronary stent trials - A case for standardized definitions [J].
Cutlip, Donald E. ;
Windecker, Stephan ;
Mehran, Roxana ;
Boam, Ashley ;
Cohen, David J. ;
van Es, Gerrit-Anne ;
Steg, P. Gabriel ;
Morel, Marie-angele ;
Mauri, Laura ;
Vranckx, Pascal ;
McFadden, Eugene ;
Lansky, Alexandra ;
Hamon, Martial ;
Krucoff, Mitchell W. ;
Serruys, Patrick W. .
CIRCULATION, 2007, 115 (17) :2344-2351
[10]   Rapamycin-eluting stents for the treatment of unprotected left main coronary disease [J].
de Lezo, JS ;
Medina, A ;
Pan, M ;
Delgado, A ;
Segura, J ;
Pavlovic, D ;
Melián, F ;
Romero, M ;
Burgos, L ;
Hernández, E ;
Ureña, I ;
Herrador, J .
AMERICAN HEART JOURNAL, 2004, 148 (03) :481-485